Nia Health

Founded in 2019 as a spin-off from Charité Universitätsmedizin Berlin, Nia Health develops medical software aimed at providing continuous digital support for patients with chronic skin conditions, such as eczema. Their AI-powered applications offer personalized content and functions to improve patient well-being, addressing an often underserved population and generating treatment-relevant real-world evidence.

Key Features:

• Personalized Patient Support: Nia Health's applications deliver tailored guidance and resources to help patients manage their skin conditions effectively. 
• AI-Driven Solutions: Utilizing artificial intelligence, the platform offers accurate documentation of disease and therapy progression, optimizing treatment plans. 
• Real-World Evidence Generation: The system collects anonymized medical information from everyday patient care, contributing to valuable insights for healthcare providers. 

Funding and Growth:

In May 2023, Nia Health secured approximately $3.75 million in seed funding, led by High-Tech Gründerfonds and adesso ventures. This investment aims to enhance the capabilities of the Nia app, conduct clinical trials, and scale the company's operations. 

Collaborations and Partnerships:

Nia Health collaborates with pharmaceutical companies, health insurance providers, and clinics to expand its reach and impact. Their expertise in real-world evidence collection offers valuable insights for stakeholders in the medical industry.

By integrating advanced technology with personalized care, Nia Health strives to improve the quality of life for individuals living with chronic skin conditions.